Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Up 243.7% in April

Nexalin Technology, Inc. (NASDAQ:NXL) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 327,200 shares, an increase of 243.7% from the March 31st total of 95,200 shares. Based on an average trading volume of 786,600 shares, the short-interest ratio is currently 0.4 days. Approximately 5.6% of the shares of the stock are sold short.

Nexalin Technology Price Performance

Shares of NXL opened at $1.39 on Friday. The firm has a 50 day simple moving average of $1.05 and a 200-day simple moving average of $0.60. Nexalin Technology has a 1-year low of $0.25 and a 1-year high of $3.40.

About Nexalin Technology

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders.